Two Versus Four Weeks of Antibiotic Treatment in Native Joint Arthritis
Arthritis, Septic
About this trial
This is an interventional treatment trial for Arthritis, Septic focused on measuring septic arthritis, surgery, antibiotic duration, remission, sequelae
Eligibility Criteria
Inclusion Criteria:
- Age >17 years
- Microbiologically-confirmed septic arthritis
- At least one surgical drainage/lavage
Exclusion Criteria:
- Presence of osteosynthesis material in the vicinity of the articulation
- Presence of a concomitant infection needing more than 2 week's of antibiotic therapy
- More than 3 surgical drainages
- Life expectancy less than 6 months
- Chronic osteomyelitis in vicinity of the arthritis
Sites / Locations
- Geneva University Hospitals
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Active Comparator
Experimental
Active Comparator
Two week's arm - surgery
Four week's arm - surgery
Two week's arm - drugs
Four week's arm - drugs
The investigators perform a surgical drainage and removal of the infected orthopedic implant.
The investigators surgically remove the infected implant.
The investigators perform a surgical drainage and removal of the infected orthopedic implant. They start an empirical antibiotic treatment based on patient's history and co-morbidities, such as vancomycin or amoxicillin/clavulanic acid. The adapt later on the targeted antibiotic therapy according to the causative pathogens and their antibiotic susceptibility testing.
The investigators surgically remove the infected implant and all soft tissue infection. Instead of a total of 2 week's of antibiotic therapy, they administer a total of 4 weeks of systemic antibiotic therapy targeted to the pathogen(s).